Headache Induced by Chronic Substance Use: Analysis of Medication Overused and Minimum Dose Required to Induce Headache

Headache

Volumn 44, Issue 2, 2004, Pages 148-153

  Relja, Giuliano ^a   Granato, Antonio ^a   Antonello, Rodolfo Maria ^a   Zorzon, Marino ^a,b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Chronic headache; Diagnostic criteria; Drug abuse; Minimum dose

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUTALBITAL PLUS CAFFEINE PLUS PROPYPHENAZONE; CAFFEINE PLUS INDOMETHACIN PLUS PROCHLORPERAZINE; CAFFEINE PLUS PARACETAMOL PLUS PROPYPHENAZONE; DELORAZEPAM; DICLOFENAC; DIPYRONE; ERGOTAMINE; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; METOCLOPRAMIDE; NAPROXEN; NIMESULIDE; PARACETAMOL; PROPYPHENAZONE; RIZATRIPTAN; S ADENOSYLMETHIONINE; SUMATRIPTAN; UNCLASSIFIED DRUG; ZOLMITRIPTAN;

ADULT; ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG OVERUSE; DRUG USE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PRIORITY JOURNAL; SUBSTANCE ABUSE; TENSION HEADACHE;

ANALGESICS, NON-NARCOTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEADACHE DISORDERS; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; SEROTONIN AGONISTS; SUBSTANCE-RELATED DISORDERS;

EID: 1242298703     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2004.04031.x     Document Type: Article

References (26)

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
2. Solomon S, Lipton RB, Newman LC. Clinical features of chronic daily headache. Headache. 1992;32:325-329.
3. Pini LA, Bigarelli M, Vitale G, Sternieri E. Headache associated with chronic use of analgesics: a therapeutic approach. Headache. 1996;36:433-439.
4. Mathew NT. Medication misuse headache. Cephalalgia. 1998;18(suppl 21):34-36.
5. Suhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Husstedt IW. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia. 1999;19:44-49.
6. Diener HC. A personal view of the classification and definition of drug dependence headache. Cephalalgia. 1993;13(suppl 12):68-71.
7. Ferrari A, Sternieri E. Consumo di analgesici e cefalee: abuso ed autoprescrizione. Confinia Cephalalgica. 1993;(suppl 2):11-16.
8. Lainez MJ. Drug abuse headache. EHF News. 1997;10:1-3.
9. Pini LA, Cicero AF, Sandrini M. Long-term follow-up of patients treated for chronic headache with analgesics overuse. Cephalalgia. 2001;21:878-883.
10. Manzoni GC, Granella F, Sandrini G, Cavallini A, Zanferrari C, Nappi G. Classification of chronic daily headache by International Headache Society criteria: limits and new proposals. Cephalalgia. 1995;15:37-43.
11. Silberstein SD, Lipton RB, Solomon S, Mathew N. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache. 1994;34:1-7.
12. Silberstein SD, Lipton RB, Sliwinski M. Assessment for revised criteria of chronic daily headache [abstract]. Neurology. 1996;45:A394.
13. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology. 1996;47:871-875.
14. Solomon S, Lipton RB, Newman LC. Evaluation of chronic daily headache-comparison to criteria for chronic tension type headache. Cephalalgia. 1992;12:365-368.
15. Diener HC, Dichgans J, Scholz S, Gerber WD, Bille A. Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol. 1989;236:9-14.
16. Mathew NT, Kurman R, Perez F. Drug induced refractory headache-clinical features and management. Headache. 1990;30:634-638.
17. Schnider P, Aull S, Baumgartner C, et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia. 1996;16:481-485.
18. Evers S, Suhr B, Bauer B, Grotemeyer KH, Husstedt IW. A retrospective long-term analysis of the epidemiology and features of drug-induced headache. J Neurol. 1999;246:802-809.
19. Fritsche G, Eber A, Katsarava Z, Limmroth V, Diener HC. Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol. 2001;45:229-35.
20. Tribl GG, Schnider P, Wober C, Aull S, Zeiler K, Wessely P. Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache? Cephalalgia. 2001;21:691-696.
21. Evers S, Gralow I, Bauer B, et al. Sumatriptan and ergotamine overuse and drug-induced headache: a clinicoepidemiologic study. Clin Neuropharmacol. 1999;22:201-206.
22. Pini LA, Relja G. Relevance of analgesic abuse in the maintenance of chronic headaches. J Headache Pain. 2000;1:S21-S26.
23. Ottervanger JP, Valkenburg HA, Grobbee DE, Stricker BH. Pattern of sumatriptan use and overuse in general practice. Eur J Clin Pharmacol. 1996;50:353-355.
24. Gaist D. Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data. Cephalalgia. 1999;19:735-761.
25. Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology. 2001;57:1694-1698.
26. Relja G, Nider G. Cefalea cronica da abuso di sumatriptan: descrizione di 9 casi. Confinia Cephalalgica. 1996;5:11-15.